<?xml version="1.0" encoding="UTF-8"?>
<p id="p0060">
 <bold>For arbidol</bold>: A multicenter, prospective study
 <xref rid="bib16" ref-type="bibr">
  <sup>16</sup>
 </xref> reported, compared with dual combination of lopinavir-ritonavir and interferon-α-2b, triple combination of arbidol can shorten the time of viral nucleic acid turning negative and hospitalization time (
 <italic>P</italic> &lt; 0.05). In addition, a retrospective study
 <xref rid="bib17" ref-type="bibr">
  <sup>17</sup>
 </xref> showed no significant difference of the time of viral nucleic acid turning negative among arbidol treatment, lopinavir-ritonavir treatment and control group (
 <italic>P</italic> &gt; 0.05).
</p>
